Glen Eagle Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.5K Buy
1,085
+806
+289% +$53K 0.01% 409
2026
Q1
$19.9K Hold
279
﹤0.01% 567
2025
Q4
$22.9K Sell
279
-21
-7% -$1.64K ﹤0.01% 560
2025
Q3
$22.5K Buy
300
+21
+8% +$1.57K ﹤0.01% 560
2025
Q2
$20.7K Sell
279
-4
-1% -$278 ﹤0.01% 546
2025
Q1
$22.8K Hold
283
﹤0.01% 532
2024
Q4
$22.1K Hold
283
﹤0.01% 539
2024
Q3
$26.6K Hold
283
﹤0.01% 526
2024
Q2
$22.1K Buy
283
+36
+15% +$2.94K ﹤0.01% 533
2024
Q1
$22.5K Sell
247
-14
-5% -$1.17K ﹤0.01% 528
2023
Q4
$20.2K Buy
261
+2
+0.8% +$140 ﹤0.01% 531
2023
Q3
$17.6K Hold
259
﹤0.01% 542
2023
Q2
$21K Buy
259
+25
+11% +$2K ﹤0.01% 524
2023
Q1
$19.2K Buy
+234
New +$16.7K ﹤0.01% 522

Other funds holding GEHC

Glen Eagle Advisors's GEHC Position: Q2 2026 in Review

Glen Eagle Advisors increased its GE HealthCare (GEHC) stake by 289% in Q2 2026, buying an estimated $53K and bringing the position to 1,085 shares worth $69.5K. The position accounts for 0.01% of the portfolio, ranked #409.

Glen Eagle Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Glen Eagle Advisors held 1,085 shares of GE HealthCare worth $69.5K as of Q2 2026.
  • Glen Eagle Advisors bought 806 GE HealthCare shares in Q2 2026, an estimated $53K.
  • GE HealthCare made up 0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #409 holding.
  • Glen Eagle Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.